Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 December 2023 | Story André Damons | Photo Charl Devenish
Dr Shezree Tiel
Top student: Dr Shezree Tiel graduated top of her class and summa cum laude during the Faculty of Health Sciences graduation ceremony on Friday.

As she achieved the goals she had set for herself, Dr Shezree Tiel, one of the latest graduates from the University of the Free State (UFS) Faculty of Health Sciences (FoHS), developed the courage to not only define her goals, but aim for even more. This is the reason she graduated not only summa cum laude, but as the top student in her year group.

Dr Tiel was one of 459 students who graduated on Friday (8 December 2023) during the FoHS’s December graduation ceremony. She graduated with a MBChB degree and is one of eight students to do so summa cum laude. During her five years of studies to become a medical doctor, she was the top student in each of her year groups.  

“I feel very excited and still in disbelief, because it has been my dream since first year to graduate cum laude, but there were moments I felt I may have to accept that it may not be possible. So, I am very delighted that despite all the challenges I faced, my dream was realised,” she said.

According to her, she decided to study at UFS as it is the only university in South Africa that offered a five-year medical degree.

Building healthier and happier communities

Talking about how she achieved this, Dr Tiel, who will be doing her community service year in her home province of Mpumalanga, said what was consistent throughout her years of study, was the need to avoid a uniform approach to studying. Instead, she continued, she embraced different ways to learn.

Said Dr Tiel: “I embraced different ways to acquire knowledge and used these to identify a method of study that would be best suited for each module, chapter and sometimes each day. Everyday courage, resilience, patience, and perseverance played a vital role in accomplishing all my achievements. In spite of all of this, I will always attribute my achievements to my trust in Christ.”

Her desire to make the best possible use of every opportunity she gets to gain knowledge and the hope to use that knowledge to be useful to people and communities, motivated her on her journey to become a doctor. She decided to study medicine because she aspired to work with people in the pursuit of building healthier and happier communities. She believed that medicine would provide a great foundation and platform to accomplish this.

Though she is yet to decide in which field she would like to specialise one day, she believes it would be in internal medicine because it has always been one of her favourite rotations. “I do hope whichever one I go into will provide me with an opportunity to teach because that is one of the things I delight in.”

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept